112 related articles for article (PubMed ID: 30848200)
1. Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology.
Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
Curr Drug Targets; 2019; 20(9):938-941. PubMed ID: 30848200
[TBL] [Abstract][Full Text] [Related]
2. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein.
Tertov VV; Kaplun VV; Sobenin IA; Boytsova EY; Bovin NV; Orekhov AN
Atherosclerosis; 2001 Nov; 159(1):103-15. PubMed ID: 11689212
[TBL] [Abstract][Full Text] [Related]
3. Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
Zhang C; Chen J; Liu Y; Xu D
Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172
[TBL] [Abstract][Full Text] [Related]
4. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
[TBL] [Abstract][Full Text] [Related]
6. Kidney sialidase and sialyltransferase activities in spontaneously and experimentally diabetic rats. Influence of insulin and sorbinil treatments.
Cohen-Forterre L; Andre J; Mozere G; Peyroux J; Sternberg M
Biochem Pharmacol; 1990 Aug; 40(3):507-13. PubMed ID: 2200408
[TBL] [Abstract][Full Text] [Related]
7. The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis.
Summerhill VI; Grechko AV; Yet SF; Sobenin IA; Orekhov AN
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330845
[TBL] [Abstract][Full Text] [Related]
8. Modulating the regioselectivity of a Pasteurella multocida sialyltransferase for biocatalytic production of 3'- and 6'-sialyllactose.
Guo Y; Jers C; Meyer AS; Li H; Kirpekar F; Mikkelsen JD
Enzyme Microb Technol; 2015 Oct; 78():54-62. PubMed ID: 26215345
[TBL] [Abstract][Full Text] [Related]
9. Directed mutagenesis of the Trypanosoma cruzi trans-sialidase enzyme identifies two domains involved in its sialyltransferase activity.
Smith LE; Eichinger D
Glycobiology; 1997 Apr; 7(3):445-51. PubMed ID: 9147054
[TBL] [Abstract][Full Text] [Related]
10. Cell surface sialylation and ecto-sialyltransferase activity of human CD34 progenitors from peripheral blood and bone marrow.
Schwartz-Albiez R; Merling A; Martin S; Haas R; Gross HJ
Glycoconj J; 2004; 21(8-9):451-9. PubMed ID: 15750786
[TBL] [Abstract][Full Text] [Related]
11. [Atherogenic modification of low-density lipoproteins].
Sukhorukov VN; Karagodin VP; Orekhov AN
Biomed Khim; 2016 May; 62(4):391-402. PubMed ID: 27562992
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of the sialidase and trans-sialidase activities of bacterial sialyltransferases from glycosyltransferase family 80.
Mehr K; Withers SG
Glycobiology; 2016 Apr; 26(4):353-9. PubMed ID: 26582604
[TBL] [Abstract][Full Text] [Related]
13. Decreasing the sialidase activity of multifunctional Pasteurella multocida α2-3-sialyltransferase 1 (PmST1) by site-directed mutagenesis.
Sugiarto G; Lau K; Li Y; Khedri Z; Yu H; Le DT; Chen X
Mol Biosyst; 2011 Nov; 7(11):3021-7. PubMed ID: 21858283
[TBL] [Abstract][Full Text] [Related]
14. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
[TBL] [Abstract][Full Text] [Related]
15. Preliminary 1H NMR investigation of sialic acid transfer by the trans-sialidase from Trypanosoma cruzi.
Wilson JC; Kiefel MJ; Albouz-Abo S; von Itzstein M
Bioorg Med Chem Lett; 2000 Dec; 10(24):2791-4. PubMed ID: 11133093
[TBL] [Abstract][Full Text] [Related]
16. A semi-multifunctional sialyltransferase from Bibersteinia trehalosi and its comparison to the Pasteurella multocida ST1 mutants.
Talafová K; Hrabárová E; Nahálka J
J Biotechnol; 2015 Dec; 216():116-24. PubMed ID: 26477829
[TBL] [Abstract][Full Text] [Related]
17. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
Tertov VV; Sobenin IA; Orekhov AN
Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a CMPNeuAc: lactosylceramide alpha 2----3sialyltransferase from rainbow trout hepatoma (RTH-149) cells.
Ostrander GK; Holmes EH
Comp Biochem Physiol B; 1991; 98(1):87-95. PubMed ID: 2060283
[TBL] [Abstract][Full Text] [Related]
19. Human plasma trans-sialidase donor and acceptor specificity.
Tertov VV; Nikonova EY; Nifant'ev NE; Bovin NV; Orekhov AN
Biochemistry (Mosc); 2002 Aug; 67(8):908-13. PubMed ID: 12223090
[TBL] [Abstract][Full Text] [Related]
20. The effect of phenobarbitone administration on sialyltransferase activity and fibrinogen bound sialic acid in rats.
Francis JL; Simmonds VJ; Armstrong DJ
Thromb Res; 1983 Aug; 31(3):507-12. PubMed ID: 20218006
[No Abstract] [Full Text] [Related]
[Next] [New Search]
